Robert Keith Warner - Jan 8, 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Jan 8, 2024
Transactions value $
-$1,013,894
Form type
4
Date filed
1/9/2024, 04:10 PM
Previous filing
Dec 12, 2023
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Sale -$700K -16.5K -69.6% $42.37 7.22K Jan 8, 2024 See footnote F1, F2, F3
transaction RXST Common Stock Sale -$314K -7.22K -100% $43.42 0 Jan 8, 2024 See footnote F1, F3, F4
holding RXST Common Stock 27.7K Jan 8, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 24, 2023 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 16,530 shares sold in the price range of $42.00 to $42.995 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.
F4 Represents the weighted average share price of an aggregate total of 7,220 shares sold in the price range of $43.085 to $43.98 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.